Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sacchi

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Haematologica|September 5, 2001
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphomaS Sacchi, M Federico, U Vitolo, et al.
Leukemia|April 29, 1998
All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phaseD Russo, M Regazzi, S Sacchi, et al.
Clinical Drug Investigation|March 29, 2008
Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week OffM B Regazzi, D Russo, I Iacona, et al.
Transplantation Proceedings|April 21, 2009
Protective effects of heparin on hepatic ischemia and reperfusion lesions in rabbitsM O Taha, P F Z R A Gonçalves, R O G Vidigal, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Haematologica|September 5, 2001
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphomaS Sacchi, M Federico, U Vitolo, et al.
Leukemia|April 29, 1998
All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phaseD Russo, M Regazzi, S Sacchi, et al.
Clinical Drug Investigation|March 29, 2008
Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week OffM B Regazzi, D Russo, I Iacona, et al.
Transplantation Proceedings|April 21, 2009
Protective effects of heparin on hepatic ischemia and reperfusion lesions in rabbitsM O Taha, P F Z R A Gonçalves, R O G Vidigal, et al.
Pageof 11